"If newly identified safety signals are identified, the FDA will determine what, if any, actions are appropriate after a thorough review of available data." These actions may include requiring labeling changes or development of a Risk Evaluation and Mitigation Strategy, a program that helps ensure a medication's benefits outweigh its risks
[10][11] Both accounts require the same core elements: a real prescription, detailed receipts, and documentation of a diagnosed medical condition
Another food derivative, epigallocatechin 3 gallate, a component of polyphenols derived from green tea, was shown to be a potent inhibitor of IL-1-induced MUC5AC gene expression and MUC5AC secretion[97] and has antioxidant activity [98]
E., Reyes, A., Nieto-Satelo, J., Feldman, L., and Cassab, G